Hypoxia inducible factor 1B (HIF-1B)
Showing 1 - 25 of >10,000
Total Antioxidant, Total Oxidant(Tos), Hypoxia Inducible
Not yet recruiting
- Carbon Monoxide Exposure
- low-flow anesthesia
- (no location specified)
Dec 18, 2022
Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A
Not yet recruiting
- Hif-1α Covid-19
- HiF-1 alpha measurement
- (no location specified)
Dec 14, 2021
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Not yet recruiting
- Hypoxia
- +3 more
- HIF 1α and LC3B expression and MMP-9 level
- (no location specified)
Apr 5, 2023
Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)
Recruiting
- Chronic Inducible Urticaria
- Oral EP262
-
Tampa, Florida
- +5 more
Sep 18, 2023
Parkinson Disease Trial in Nijmegen (Hypoxia through modified hypoxic generator, Normoxia through hypoxic generator without
Recruiting
- Parkinson Disease
- Hypoxia through modified hypoxic generator
- Normoxia through hypoxic generator without active elements
-
Nijmegen, Netherlands
- +1 more
Jul 13, 2023
Healthy Volunteers Trial in Hannover (CSL324, Placebo)
Recruiting
- Healthy Volunteers
- CSL324
- Placebo
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023
Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)
Recruiting
- Anemia in Dialysis-dependent CKD Patients
-
Alexandria, EgyptAlexandria University
Oct 29, 2023
Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)
Recruiting
- Hemophilia A
- Hemophilia B
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
- +3 more
Jan 18, 2023
Advanced Breast Cancer Trial in Dallas (PD-0332991 and T-DM1)
Completed
- Advanced Breast Cancer
- PD-0332991 and T-DM1
-
Dallas, TexasUT Southwestern Medical Center
Jan 24, 2022
Cold Urticaria Trial in Worldwide (Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine)
Active, not recruiting
- Cold Urticaria
- Dupilumab SAR231893
- +2 more
-
San Diego, California
- +34 more
Nov 15, 2022
COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,
Not yet recruiting
- COPD Exacerbation Acute
- +2 more
- Interleukin-1B
- +4 more
- (no location specified)
Mar 23, 2023
Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Beijing, Beijing, China
- +16 more
Jun 2, 2023
Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule
Recruiting
- Cardiovascular Diseases
- +3 more
- Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
-
North York, Ontario, Canada
- +3 more
Nov 7, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +7 more
-
Portland, OregonSWOG
Sep 27, 2023
Breast Cancer Trial in Baltimore (Digoxin)
Completed
- Breast Cancer
-
Baltimore, MarylandKimmel Cancer Center at Johns Hopkins
Jan 22, 2020
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Hemophilia B Trial in Los Angeles (verbrinacogene setparvovec)
Recruiting
- Hemophilia B
- verbrinacogene setparvovec
-
Los Angeles, CaliforniaChildren's Hospital of Los Angeles
Jan 7, 2022
